Not far away, Liberty Property Trust in late July announced that DrugDev has signed a lease agreement for 31,000 square feet of Class A office space at 1170 Devon Park Drive in Wayne, Pa. The 88,000-sq.-ft., three-story building (pictured below), which will serve as the US headquarters for DrugDev, recently underwent a $2.5-million renovation. DrugDev, currently headquartered in London and Audubon, Pa., provides technology-enabled solutions to help clinical study sponsors, CROs and investigative sites do more trials together.
“This area has seen a significant amount of public and private investment recently, including road improvements, the recently opened Chester Valley Trail, the continued development of the Village at Valley Forge and the construction and/or renovation of several office buildings. That investment, combined with the formation of the King of Prussia Business Improvement District, has made this section of the 202 corridor very attractive to high-profile tenants like DrugDev,” said Bruce Hartlein, vice president leasing and development, Liberty Property Trust.”
“Our new United States headquarters provides a significant upgrade to support DrugDev and our ongoing growth,” said Ibraheem Mahmood, CEO of DrugDev. “While our current location has served us well, we are excited to have secured a facility which features quality amenities that are important to employees as we continue to expand our business operations. The building offers an excellent blend of what we need and what we want, and we look forward to many productive years of improving how global clinical trials are conducted from our new home in King of Prussia, Pa.”